Delivery Order SPE2DB20D3103-SPE2DB25FN9L2
Award Date
5/23/25
Potential Completion Date
5/27/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,546.31 fixed-price contract is for the delivery of 100-count packages of the prescription medication Vyvanse 50 mg capsules. The contract has a performance period ending on May 2, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a $1,337.97 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 10mg Vyvanse capsules. The contract has a completion date of September 20, 2024 and was awarded on September 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,737.44, is for the delivery of 100 units of the medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 100 capsules of the medication Vyvanse 50 mg, with a ceiling value of $1,488.14 and a period of performance through April 2025. The contract is not set-aside and was awarded as part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that enables AmerisourceBergen to provide a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,758.99, is for the delivery of 100 units of the medication Vyvanse 30 mg capsule. The contract has an ultimate completion date of April 24, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $6,120.52 firm fixed-price contract is for the supply of Vyvanse 50mg capsules, a prescription medication. The ultimate completion date is September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 100-count capsules of the prescription medication Vyvanse (lisdexamfetamine dimesylate) 50 mg. The contract has a firm fixed price of $11,010.42 and a period of performance through May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,060,938 units of the prescription medication Vyvanse 60 mg capsules. The contract has a firm fixed price of $1,143.32 and a period of performance through April 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,537.27 firm fixed-price delivery order is for the supply of Vyvanse 50 mg capsules, a prescription medication. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,368.57 contract is for the delivery of 4,564,529,038 units of the medication Vyvanse (40 mg capsules) with a performance period through May 8, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...